FDA approves Rezdiffra for nonalcoholic steatohepatitis
Mar 15, 2024
Drug was approved on an ‘accelerated’ schedule due to pressing medical need
Statin initiation cuts mortality in older adults with chronic kidney disease
Jan 05, 2024
The findings were seen among older adults with stage 3 to 4 disease with no prior atherosclerotic cardiovascular disease.
Statin use increased from 1999-2000 to 2013-2014, then plateaued
Dec 04, 2023
No change was seen in the proportion using statins from 2013-2014 to 2017-2018 for those with diabetes and with ASCVD risk greater than 20%.
Lipid-lowering drugs save lives, but use decreasing
Dec 01, 2023
In 2019 to 2020, 56% of patients with high cholesterol were on statins for primary prevention and 85% were on them for secondary prevention.
High-intensity statins underused with atherosclerotic cardiovascular disease
Sep 19, 2023
The authors say that the findings show gaps between practice and guideline-based care.
Drop in LDL cholesterol greater with low-, moderate-intensity statins for seniors
Aug 01, 2023
Initiators of statins aged 75 years or older had a higher mean percentage reduction than those younger than 50 years.
ADA: Bempedoic acid cuts MACE in statin-intolerant patients
Jun 26, 2023
Significant risk reduction was observed in the primary end point of composite of cardiovascular death nonfatal myocardial infarction, nonfatal stroke, coronary revascularization.
Statin use linked to reduced risk for intracerebral hemorrhage
Dec 07, 2022
The risk was reduced for lobar and nonlobar intracerebral hemorrhage; greater reductions were seen with prolonged use of ≥5 years.
Cardiovascular benefits of statins outweigh low risk for muscle symptoms
Aug 30, 2022
Only one of 15 muscle symptom-related reports by study participants assigned to statins were believed to be due to statins.
Guidance developed for addressing use of nonstatin therapies
Aug 29, 2022
An expert consensus decision pathway was developed for patients currently taking statins and needing additional treatment.